• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量冻干制剂产生的用于干粉吸入的多孔颗粒空气动力学粒径分布的简单方法。

Simple Method to Measure the Aerodynamic Size Distribution of Porous Particles Generated on Lyophilizate for Dry Powder Inhalation.

作者信息

Miyamoto Kahori, Taga Hiroaki, Akita Tomomi, Yamashita Chikamasa

机构信息

Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.

出版信息

Pharmaceutics. 2020 Oct 15;12(10):976. doi: 10.3390/pharmaceutics12100976.

DOI:10.3390/pharmaceutics12100976
PMID:33076510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7650659/
Abstract

Recently, statistical techniques such as design of experiments are being applied for efficient optimization of oral formulations. To use these statistical techniques for inhalation formulations, efficient methods for rapid determination of the aerodynamic particle size distribution of many samples are needed. Therefore, we aimed to develop a simple method to measure aerodynamic particle size distribution that closely agrees with the results of inhalation characteristic tests. We added attachments for dispersion to the aerodynamic particle sizer (APS) so that formulations could be dispersed under the same condition as for multi-stage liquid impinger (MSLI) measurement. Then, we examined the correlation between MSLI and APS using lyophilizate for dry powder inhalation formulations that generate porous particles just on inhalation. It is difficult to obtain the accurate aerodynamic particle size distribution of porous particles by APS because the particle density is difficult to estimate accurately. However, there was a significant correlation between MSLI and APS when the particle density settings for APS measurement was calculated by a conversion factor based on the result of MSLI. The APS with dispersion attachments and this conversion factor can measure a number of samples in a short time, thereby enabling more efficient optimization of dry powder inhalers.

摘要

最近,诸如实验设计等统计技术正被应用于口服制剂的高效优化。为了将这些统计技术用于吸入制剂,需要有能快速测定多个样品空气动力学粒径分布的有效方法。因此,我们旨在开发一种简单的方法来测量空气动力学粒径分布,使其与吸入特性测试结果高度吻合。我们在空气动力学粒度分析仪(APS)上添加了分散附件,以便制剂能在与多级液体冲击器(MSLI)测量相同的条件下分散。然后,我们使用用于干粉吸入制剂的冻干品来研究MSLI和APS之间的相关性,该冻干品在吸入时会产生多孔颗粒。通过APS很难获得多孔颗粒准确的空气动力学粒径分布,因为颗粒密度难以准确估计。然而,当基于MSLI的结果通过换算系数计算APS测量的颗粒密度设置时,MSLI和APS之间存在显著相关性。带有分散附件的APS和此换算系数可以在短时间内测量多个样品,从而实现干粉吸入器更高效的优化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/0d64533b35fe/pharmaceutics-12-00976-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/1838cf99cfab/pharmaceutics-12-00976-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/34f76e1131cd/pharmaceutics-12-00976-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/07a9073d1b0f/pharmaceutics-12-00976-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/fcf2ffdb3df4/pharmaceutics-12-00976-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/6fe11c7a85a4/pharmaceutics-12-00976-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/0b069b711154/pharmaceutics-12-00976-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/0d64533b35fe/pharmaceutics-12-00976-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/1838cf99cfab/pharmaceutics-12-00976-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/34f76e1131cd/pharmaceutics-12-00976-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/07a9073d1b0f/pharmaceutics-12-00976-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/fcf2ffdb3df4/pharmaceutics-12-00976-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/6fe11c7a85a4/pharmaceutics-12-00976-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/0b069b711154/pharmaceutics-12-00976-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8609/7650659/0d64533b35fe/pharmaceutics-12-00976-g007.jpg

相似文献

1
Simple Method to Measure the Aerodynamic Size Distribution of Porous Particles Generated on Lyophilizate for Dry Powder Inhalation.测量冻干制剂产生的用于干粉吸入的多孔颗粒空气动力学粒径分布的简单方法。
Pharmaceutics. 2020 Oct 15;12(10):976. doi: 10.3390/pharmaceutics12100976.
2
Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory.基于飞行时间理论的简单方法对用于干粉吸入系统的维生素D3冻干物极低剂量制剂进行优化。
Pharmaceutics. 2021 Apr 29;13(5):632. doi: 10.3390/pharmaceutics13050632.
3
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.湿度引起的含有不同载体的干粉气雾剂制剂空气动力学性质的变化。
Int J Pharm. 2007 Mar 21;333(1-2):45-55. doi: 10.1016/j.ijpharm.2006.09.048. Epub 2006 Oct 1.
4
Novel dry powder inhalation system based on dispersion of lyophilisates.基于冻干制剂分散的新型干粉吸入系统。
Eur J Pharm Sci. 2011 May 18;43(1-2):32-40. doi: 10.1016/j.ejps.2011.03.005. Epub 2011 Mar 31.
5
Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.粉末透气度:干粉吸入器制剂开发的潜在工具。
Eur J Pharm Biopharm. 2010 Nov;76(3):464-9. doi: 10.1016/j.ejpb.2010.09.003. Epub 2010 Sep 18.
6
Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations.用于干粉吸入制剂冻干品的放射性标记方法。
Pharmaceutics. 2022 Mar 31;14(4):759. doi: 10.3390/pharmaceutics14040759.
7
The effect of dose on the characterization of aerodynamic particle-size distributions of beclomethasone dipropionate metered-dose inhalers.剂量对丙酸倍氯米松定量吸入器空气动力学粒径分布特征的影响。
J Pharm Pharmacol. 1998 Oct;50(10):1081-5. doi: 10.1111/j.2042-7158.1998.tb03316.x.
8
Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.定量压力吸入气雾剂的气溶胶空气动力学粒径分析:Andersen八级阶式撞击器、新一代药物撞击器和3321型空气动力学粒径分析仪的比较
AAPS PharmSciTech. 2003 Oct 22;4(4):E54. doi: 10.1208/pt040454.
9
Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology.使用超临界流体技术生产的聚乳酸干粉制剂在人体气道模型中的颗粒特性及肺部沉积模式。
J Aerosol Med. 2003 Spring;16(1):65-73. doi: 10.1089/089426803764928374.
10
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.用于测定雾化粉末制剂粒度的激光衍射方法的开发。
Int J Pharm. 2006 Dec 1;326(1-2):39-49. doi: 10.1016/j.ijpharm.2006.07.021. Epub 2006 Jul 16.

引用本文的文献

1
Development of Voriconazole Proliposome Based Dry Powder for Inhalation: A Design of Experiment Approach.伏立康唑前体脂质体吸入用干粉的研制:一种实验设计方法。
Pharmaceutics. 2025 May 8;17(5):622. doi: 10.3390/pharmaceutics17050622.
2
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.干粉吸入器中使用的不同载体:其颗粒特性
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):307-327. doi: 10.1089/jamp.2023.0029. Epub 2024 Aug 9.
3
Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations.

本文引用的文献

1
Development, In Vitro Characterization, and In Vivo Toxicity Evaluation of Chitosan-Alginate Nanoporous Carriers Loaded with Cisplatin for Lung Cancer Treatment.载顺铂壳聚糖-海藻酸钠纳米多孔载体的研制、体外表征及体内毒性评价用于肺癌治疗。
AAPS PharmSciTech. 2020 Jul 13;21(5):191. doi: 10.1208/s12249-020-01735-8.
2
Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery.载有美洛昔康的喷雾干燥无孔和大孔颗粒的制剂及比较研究用于肺部药物传递。
Int J Pharm. 2019 Mar 25;559:68-75. doi: 10.1016/j.ijpharm.2019.01.034. Epub 2019 Jan 21.
3
Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin.
用于干粉吸入制剂冻干品的放射性标记方法。
Pharmaceutics. 2022 Mar 31;14(4):759. doi: 10.3390/pharmaceutics14040759.
4
Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline.通过质量源于设计理念合理开发用于呼吸道病毒感染的无载体干粉吸入制剂:法匹拉韦与茶碱的药物-药物共晶
Pharmaceutics. 2022 Jan 27;14(2):300. doi: 10.3390/pharmaceutics14020300.
5
Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives.数字化时代的干粉吸入器:现状与未来展望
Pharmaceutics. 2021 Sep 12;13(9):1455. doi: 10.3390/pharmaceutics13091455.
6
Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory.基于飞行时间理论的简单方法对用于干粉吸入系统的维生素D3冻干物极低剂量制剂进行优化。
Pharmaceutics. 2021 Apr 29;13(5):632. doi: 10.3390/pharmaceutics13050632.
7
Systemic Delivery of hGhrelin Derivative by Lyophilizate for Dry Powder Inhalation System in Monkeys.冻干物通过干粉吸入系统对猴进行hGhrelin衍生物的全身给药。
Pharmaceutics. 2021 Feb 7;13(2):233. doi: 10.3390/pharmaceutics13020233.
利用葡聚糖作为赋形剂制备多孔颗粒,增强利福平肺部深部递送。
Int J Pharm. 2019 Jan 30;555:280-290. doi: 10.1016/j.ijpharm.2018.11.055. Epub 2018 Nov 22.
4
Characterisation of pore structures of pharmaceutical tablets: A review.药物片剂的孔隙结构特征:综述。
Int J Pharm. 2018 Mar 1;538(1-2):188-214. doi: 10.1016/j.ijpharm.2018.01.017. Epub 2018 Jan 16.
5
Large porous particles for respiratory drug delivery. Glycine-based formulations.用于呼吸道药物输送的大孔颗粒。基于甘氨酸的配方。
Eur J Pharm Sci. 2017 Dec 15;110:148-156. doi: 10.1016/j.ejps.2017.05.007. Epub 2017 May 4.
6
Effect of 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carbamoyl]Benzoic Acid (Am80) on Alveolar Regeneration in Adiponectin Deficient-Mice Showing a Chronic Obstructive Pulmonary Disease-Like Pathophysiology.4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸(Am80)对呈现慢性阻塞性肺疾病样病理生理学的脂联素缺乏小鼠肺泡再生的影响
J Pharmacol Exp Ther. 2017 Jun;361(3):501-505. doi: 10.1124/jpet.117.240515. Epub 2017 Apr 21.
7
Lyophilized Drug Product Cake Appearance: What Is Acceptable?冻干药品的块状外观:什么是可接受的?
J Pharm Sci. 2017 Jul;106(7):1706-1721. doi: 10.1016/j.xphs.2017.03.014. Epub 2017 Mar 22.
8
Formulation Design of Dry Powders for Inhalation.吸入用干粉剂的处方设计
J Pharm Sci. 2015 Oct;104(10):3259-88. doi: 10.1002/jps.24574. Epub 2015 Aug 21.
9
Measurement of shrinkage and cracking in lyophilized amorphous cakes. Part I: final-product assessment.冻干无定形块状物收缩和开裂的测量。第一部分:最终产品评估。
J Pharm Sci. 2015 Jan;104(1):155-64. doi: 10.1002/jps.24284. Epub 2014 Nov 24.
10
Pulmonary administration of Am80 regenerates collapsed alveoli.肺内给予 Am80 可使塌陷的肺泡再生。
J Control Release. 2014 Dec 28;196:154-60. doi: 10.1016/j.jconrel.2014.10.004. Epub 2014 Oct 13.